Brief: Orphazyme: Anders Vadsholt To Be Appointed CEO

Strategic Partners A/S

31/01/2022 16:02

Jan 31 (Reuters) - Orphazyme A/S  ORPHA.CO :
    * REG-CHANGES TO THE EXECUTIVE MANAGEMENT OF ORPHAZYME –
ANDERS
VADSHOLT TO BE APPOINTED CEO
    * EFFECTIVE APRIL 1, 2022, CHIEF FINANCIAL OFFICER (CFO),
ANDERS
VADSHOLT, WILL BE APPOINTED CEO OF ORPHAZYME
    * CHIEF EXECUTIVE OFFICER (CEO) CHRISTOPHE BOURDON WILL
RESIGN
FROM HIS POSITION AS CEO AT ORPHAZYME A/S TO TAKE ON ROLE AS CEO
OF LEO PHARMA A/S

Source text for Eikon:  ID:nGNE2hHH4R 
Further company coverage:  ORPHA.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))